Low-dose, short course alteplase treatment of submassive pulmonary embolism-Reference-Cited by-同舟云学术

Low-dose, short course alteplase treatment of submassive pulmonary embolism

Published:2018-12 Issue:8 Volume:29 Page:701-707
ISSN:0957-5235
Container-title:Blood Coagulation & Fibrinolysis
language:en
Short-container-title:

Author:

Lozier Jay N.,Elinoff Jason M.,Suffredini Anthony F.,Rosing Douglas R.,Sidenko Stanislav,Sherry Richard M.,Metwalli Adam R.,Sachdev Vandana,Danner Robert L.,Chang Richard

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Hematology,General Medicine

Reference23 articles.

1. Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report;Kearon;Chest,2016

2. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association;Jaff;Circulation,2011

3. Thrombolysis or heparin therapy in massive pulmonary embolism with right ventricular dilation: results from a 128-patient monocenter registry;Hamel;Chest,2001

4. PAIMS 2: alteplase combined with heparin versus heparin in the treatment of acute pulmonary embolism. Plasminogen activator Italian multicenter study 2;Dalla-Volta;J Am Coll Cardiol,1992

5. Effects of intravenous urokinase versus alteplase on total pulmonary resistance in acute massive pulmonary embolism: a European multicenter double-blind trial. The European Cooperative Study Group for Pulmonary Embolism;Meyer;J Am Coll Cardiol,1992

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low-dose thrombolytic therapy versus unfractionated heparin in patients with intermediate-high risk pulmonary embolism;Turkish Journal of Trauma and Emergency Surgery;2023

2. Clinical safety and efficacy of thrombolytic therapy with low-dose prolonged infusion of tissue type plasminogen activator in patients with intermediate-high risk pulmonary embolism;Blood Coagulation & Fibrinolysis;2020-12

3. Alteplase/heparin;Reactions Weekly;2019-06

4. Safety and effectiveness of thrombolytics compared to standard anticoagulation in subjects with submassive pulmonary embolism;Erciyes Medical Journal;2019